<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN"
        "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article  article-type="research-article"        dtd-version="1.4">
            <front>

                <journal-meta>
                                                                <journal-id>hujpharm</journal-id>
            <journal-title-group>
                                                                                    <journal-title>Hacettepe University Journal of the Faculty of Pharmacy</journal-title>
            </journal-title-group>
                                        <issn pub-type="epub">2458-8806</issn>
                                                                                            <publisher>
                    <publisher-name>Hacettepe University</publisher-name>
                </publisher>
                    </journal-meta>
                <article-meta>
                                        <article-id pub-id-type="doi">10.52794/hujpharm.1649224</article-id>
                                                                <article-categories>
                                            <subj-group  xml:lang="en">
                                                            <subject>Pharmaceutical Analytical Chemistry</subject>
                                                    </subj-group>
                                            <subj-group  xml:lang="tr">
                                                            <subject>Eczacılıkta Analitik Kimya</subject>
                                                    </subj-group>
                                    </article-categories>
                                                                                                                                                        <title-group>
                                                                                                                        <article-title>Quantification of Edoxaban Tosylate Monohydrate in Pharmaceutical API And Dosage Form by a Novel UV-Spectrophotmetric Method: Development and Validation</article-title>
                                                                                                                                        </title-group>
            
                                                    <contrib-group content-type="authors">
                                                                        <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0003-3862-0590</contrib-id>
                                                                <name>
                                    <surname>Dadi</surname>
                                    <given-names>Vasudha</given-names>
                                </name>
                                                                    <aff>Vignan Institute of Pharmaceutical Technology</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0002-0474-546X</contrib-id>
                                                                <name>
                                    <surname>Gandi</surname>
                                    <given-names>Anusha</given-names>
                                </name>
                                                                    <aff>Vignan Institute of Pharmaceutical Technology</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0009-0002-9842-4137</contrib-id>
                                                                <name>
                                    <surname>Adari</surname>
                                    <given-names>Jagadeesh</given-names>
                                </name>
                                                                    <aff>GITAM School of Technology</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0009-0004-1731-0408</contrib-id>
                                                                <name>
                                    <surname>Sappa</surname>
                                    <given-names>Manoj Kumar</given-names>
                                </name>
                                                                    <aff>Vignan Institute of Pharmaceutical Technology</aff>
                                                            </contrib>
                                                    <contrib contrib-type="author">
                                                                    <contrib-id contrib-id-type="orcid">
                                        https://orcid.org/0000-0003-2967-1169</contrib-id>
                                                                <name>
                                    <surname>Kollabathula</surname>
                                    <given-names>Varaprasada Rao</given-names>
                                </name>
                                                                    <aff>Vignan Institute of Pharmaceutical Technology</aff>
                                                            </contrib>
                                                                                </contrib-group>
                        
                                        <pub-date pub-type="pub" iso-8601-date="20251201">
                    <day>12</day>
                    <month>01</month>
                    <year>2025</year>
                </pub-date>
                                        <volume>45</volume>
                                        <issue>4</issue>
                                        <fpage>329</fpage>
                                        <lpage>337</lpage>
                        
                        <history>
                                    <date date-type="received" iso-8601-date="20250301">
                        <day>03</day>
                        <month>01</month>
                        <year>2025</year>
                    </date>
                                                    <date date-type="accepted" iso-8601-date="20250919">
                        <day>09</day>
                        <month>19</month>
                        <year>2025</year>
                    </date>
                            </history>
                                        <permissions>
                    <copyright-statement>Copyright © 1981, Hacettepe University Journal of the Faculty of Pharmacy</copyright-statement>
                    <copyright-year>1981</copyright-year>
                    <copyright-holder>Hacettepe University Journal of the Faculty of Pharmacy</copyright-holder>
                </permissions>
            
                                                                                                <abstract><p>The major purpose of this analysis is to develop and validate easy, economic UV-spectrophotometric method useful in the quantification of Edoxaban tosylate monohydrate in active pharmaceutical ingredients (APIs). Standard and working solutions of Edoxaban tosylate monohydrate were prepared, followed by the preparation of aliquots of working solutions at various concentrations. The method was validated by assessing key parameters, including linearity, precision, accuracy, robustness, ruggedness, and the limits of detection and quantitation. The demonstrated method has excellent linearity for Edoxaban in the concentration range of 2-24 μg/mL, with a coefficient of determination (R²) was 0.9998. This method is suitable for routine analysis of Edoxaban in bulk form, offering a reliable tool for quality control in pharmaceutical settings.</p></abstract>
                                                                                    
            
                                                            <kwd-group>
                                                    <kwd>Edoxaban</kwd>
                                                    <kwd>  Method development</kwd>
                                                    <kwd>  UV Spectrometry</kwd>
                                                    <kwd>  Validation</kwd>
                                            </kwd-group>
                                                        
                                                                                                                                                    </article-meta>
    </front>
    <back>
                            <ref-list>
                                    <ref id="ref1">
                        <label>1</label>
                        <mixed-citation publication-type="journal">1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-733. https://doi.org/10.1056/NEJMoa2001017</mixed-citation>
                    </ref>
                                    <ref id="ref2">
                        <label>2</label>
                        <mixed-citation publication-type="journal">2. Bathala MS, Masumoto H, Oguma T, He L, Lowrie C, Mendell J. Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans. Drug Metab Dispos. 2012;40(12):2250-2255. https://doi.org/10.1124/dmd.112.046888</mixed-citation>
                    </ref>
                                    <ref id="ref3">
                        <label>3</label>
                        <mixed-citation publication-type="journal">3. Gous T, Couchman L, Patel JP, Paradzai C, Arya R, Flanagan RJ. Measurement of the direct oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in human plasma using turbulent flow liquid chromatography with high-resolutionmass spectrometry. Ther Drug Monit. 2014;36(5):597-605. https://doi.org/10.1097/FTD.0000000000000059</mixed-citation>
                    </ref>
                                    <ref id="ref4">
                        <label>4</label>
                        <mixed-citation publication-type="journal">4. Zhang WL, Lou D, Zhang D, Zhang Y, Huang HJ. Determination of rivaroxaban, apixaban and edoxaban in rat plasma by UPLC–MS/MS method. J Thromb Thrombolysis. 2016;42(2):205-211. https://doi.org/10.1007/s11239-016-1367-y</mixed-citation>
                    </ref>
                                    <ref id="ref5">
                        <label>5</label>
                        <mixed-citation publication-type="journal">5. Karajgi S, Kulkarni RV, Potadar S, Ingale A, Patil S, Chetan M. Quantitative detection of rebamipide by zero-order uv-spectrophotometry using dimethyl formamide solvent system. Res J Pharm Technol. 2024;17(7):3353-3357.https://doi.org/10.52711/0974-360X.2024.00524</mixed-citation>
                    </ref>
                                    <ref id="ref6">
                        <label>6</label>
                        <mixed-citation publication-type="journal">6. Lindahl S, Dyrkorn R, Spigset O, Hegstad S. Quantification of apixaban, dabigatran, edoxaban, and rivaroxaban in human serum by UHPLC-MS/MS: method development, validation, and application. Ther Drug Monit. 2018;40(33):369-376. https://doi.org/10.1097/FTD.0000000000000509</mixed-citation>
                    </ref>
                                    <ref id="ref7">
                        <label>7</label>
                        <mixed-citation publication-type="journal">7. Wiesen MHJ, Blaich C, Streichert T, Michels G, Müller C. Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS. Clin Chem Lab Med. 2017;55(9):1349-1359. https://doi.org/10.1515/cclm-2016-0888.</mixed-citation>
                    </ref>
                                    <ref id="ref8">
                        <label>8</label>
                        <mixed-citation publication-type="journal">8. Dhiware TK, Patil PA, Salaraya MG. Development and validation of HPTLC method for determination of edoxaban in bulk and tablet. Asian J Pharm Anal. 2019;9(3):161-166. https://doi.org/10.5958/2231-5675.2019.00029.2</mixed-citation>
                    </ref>
                                    <ref id="ref9">
                        <label>9</label>
                        <mixed-citation publication-type="journal">9. Reddy PS, Jagarlapudi VSK, Sekharan CB. Determination of edoxaban in bulk and in tablet dosage form by stability indicating high-performance liquid chromatography. Pharm Sci. 2016;22(1):35-41. https://doi.org/10.15171/PS.2016.07.</mixed-citation>
                    </ref>
                                    <ref id="ref10">
                        <label>10</label>
                        <mixed-citation publication-type="journal">10. Abdulkadir Kiliç, Mehmet Aslan, Abdulkadir Levent, Investigation of the electrochemical properties of edoxaban using glassy carbon and boron-doped diamond electrodes and development of an eco-friendly and cost effective voltammetric method for its determination,Analytical Biochemistry, Volume 685,2024,115386,ISSN 0003-2697. https://doi.org/10.1016/j.ab.2023.115386.</mixed-citation>
                    </ref>
                                    <ref id="ref11">
                        <label>11</label>
                        <mixed-citation publication-type="journal">11. Kiliç A, Aslan M, Önal G, Levent A. Firstly electrochemical investigetions and determination of anticoagulant drug edoxaban at single-use pencil graphite electrode: an eco-friendly and cost effective voltammetric method. Daru. 2023 Dec;31(2):233-241. doi: 10.1007/s40199-023-00478-8. Epub 2023 Sep 11. https://doi.org/10.1007/s40199-023-00478-8</mixed-citation>
                    </ref>
                                    <ref id="ref12">
                        <label>12</label>
                        <mixed-citation publication-type="journal">12. Ravisankar P. Development and validation of UV spectrophotometric method for the determination of edoxaban tosylate monohydrate in pharmaceutical dosage form. Indian J Res Pharm Biotechnol. 2018;6(2):73-78. https://doi.org/20.62062/02022073-7820Hacettepe</mixed-citation>
                    </ref>
                                    <ref id="ref13">
                        <label>13</label>
                        <mixed-citation publication-type="journal">13. Chourasiya K, Chakraborty AK. Analytical method development and validation for the simultaneous estimation of candesartan and simvastatin by UV-spectrophotometry method. Res J Pharm Technol. 2024;17(7):3151-3155.https://doi.org/10.52711/0974-360X.2024.00492</mixed-citation>
                    </ref>
                                    <ref id="ref14">
                        <label>14</label>
                        <mixed-citation publication-type="journal">14. Lindahl S, Dyrkorn R, Spigset O, Hegstad S. Quantification of apixaban, dabigatran, edoxaban, and rivaroxaban in human serum by UHPLC-MS/MS: method development, validation, and application. Ther Drug Monit. 2018;40(33):369-376. https://doi.org/10.1097/FTD.0000000000000509</mixed-citation>
                    </ref>
                                    <ref id="ref15">
                        <label>15</label>
                        <mixed-citation publication-type="journal">15. Aabid M, Memon S, Pathan D, Hangad T. Development and validation of a UV spectroscopic method to estimate eltrombopag olamine along with bulk and in-house formulation. Res J Pharm Technol. 2023;16(11):5010-5014. https://doi.org/10.52711/0974-360X.2023.00811</mixed-citation>
                    </ref>
                                    <ref id="ref16">
                        <label>16</label>
                        <mixed-citation publication-type="journal">16. Aher KB, Bhavar GB, Shelke MR, Sayyad SF. Environmentally friendly analytical methods for quantitative measurement of sofosbuvir in pharmaceutical formulations: comparison of HPTLC and UV spectrophotometric approaches. Res J Pharm Technol. 2023;16(8):3830-3836.https://doi.org/10.52711/0974-360X.2023.00632</mixed-citation>
                    </ref>
                                    <ref id="ref17">
                        <label>17</label>
                        <mixed-citation publication-type="journal">17. Chauhan NP, Surti N, Patel MP. Analytical method development and validation of methoxy-poly(ethylene glycol)-succinimidyl succinate linker by UV spectroscopy. Res J Pharm Technol. 2023;16(7):3275-3279.https://doi.org/10.52711/0974-360X.2023.00539</mixed-citation>
                    </ref>
                                    <ref id="ref18">
                        <label>18</label>
                        <mixed-citation publication-type="journal">18. Karajgi S, Kulkarni RV, Potadar S, Ingale A, Patil S, Chetan M. Quantitative detection of rebamipide by zero-order UV-spectrophotometry using dimethyl formamide solvent system. Res J Pharm Technol. 2024;17(7):3353-3357.https://doi.org/10.52711/0974-360X.2024.00524</mixed-citation>
                    </ref>
                                    <ref id="ref19">
                        <label>19</label>
                        <mixed-citation publication-type="journal">19. Anusha G, Nargiz S, Sireesha A, Poojitha K, Rao KV, Rao YS. Green solvent-based uv spectrophotometric technique for quantifying molnupiravir in bulk and pharmaceutical formulation. Res J Pharm Technol. 2024;17(11):5210-4. https://doi.org/10.52711/0974-360X.2024.00797.</mixed-citation>
                    </ref>
                                    <ref id="ref20">
                        <label>20</label>
                        <mixed-citation publication-type="journal">20. Panda M, Dadi V, Yarraguntla SR, Rao VP. RP-HPLC method for determination of azelnidipine and telmisartan in pharmaceutical dosage form. Res J Pharm Technol. 2023;16(2):509-13. https://doi.org/10.52711/0974-360X.2023.00086.</mixed-citation>
                    </ref>
                                    <ref id="ref21">
                        <label>21</label>
                        <mixed-citation publication-type="journal">21. Rao K, Prasad V, Vasudha D. Visible Spectrophotometry Methods for The Estimation of Modafinil In Pharmaceutical Formulation. Indian Drugs. 2022 Sep 1;59(9). https://doi.org/10.53879/id.59.09.10283.</mixed-citation>
                    </ref>
                                    <ref id="ref22">
                        <label>22</label>
                        <mixed-citation publication-type="journal">22. Gandi A, Dudi PK, Pantala ES, K VR, Yarguntla SR. A Comprehensive New Approach to Method Development and Validation of Encorafenib using UV Spectroscopy in Bulk and Pharmaceutical Formulation. HUJPHARM. 2024;44(4):318-27. https://doi.org/10.52794/hujpharm.1479058.</mixed-citation>
                    </ref>
                                    <ref id="ref23">
                        <label>23</label>
                        <mixed-citation publication-type="journal">23. Srinivasarao Y, Kumar TH, Chiranjivi P, Rao KV. Simultaneous Estimation of Solifenacin Succinate and Tamsulosin Hydrochloride in Combined Dosage Form by Using First Order Derivative Spectrophotometric Method. Indian Journal of Pharmaceutical Sciences. 2021;83(2).</mixed-citation>
                    </ref>
                                    <ref id="ref24">
                        <label>24</label>
                        <mixed-citation publication-type="journal">24. Lakshmi GT, Rao YS, Rao K, Prasada V, Kumar TH. RP-HPLC method for estimation of atomoxetine hydrochloride in bulk and pharmaceutical dosage form. Research Journal of Pharmaceutical Biological and Chemical Sciences. 2015;6(2):1208-14.</mixed-citation>
                    </ref>
                            </ref-list>
                    </back>
    </article>
